The lengthening list of pharma alliances focused on molecular glue degraders has another entry after Novartis signed a deal with Monte Rosa Therapeutics worth up to $2.2 billion. The partnership ...

09h55 Capítulo 5: Quatro décadas de luta 09h17 Capítulo 4: Índio não quer mesada 08h57 Capítulo 3: Altamira invadida 08h52 Capítulo 2: A Volta Grande do Xingu 08h45 Capítulo 1: Um projeto ...

Thank you for reporting this station. We will review the data in question. You are about to report this weather station for bad data. Please select the information that is incorrect.